Madrigal Pharmaceuticals, Inc. Share Price
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 560.01 USD | -0.95% |
|
+6.04% | -3.83% |
| Market Cap | 12.91B 11.29B 10.42B 9.64B 18.29B 1,232B 18.6B 125B 48.9B 605B 48.47B 47.42B 2,096B | P/E 2026 * |
-80.3x | P/E 2027 * | 56.7x |
|---|---|---|---|---|---|
| Enterprise Value | 12.38B 10.83B 9.99B 9.24B 17.54B 1,182B 17.84B 120B 46.89B 580B 46.48B 45.48B 2,010B | EV / Sales 2026 * |
8.28x | EV / Sales 2027 * | 5.36x |
| Free-Float |
94.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | -0.95% | ||
| 1 week | +6.04% | ||
| Current month | +4.29% | ||
| 1 month | +17.43% | ||
| 3 months | +6.81% | ||
| 6 months | +8.94% | ||
| Current year | -3.83% |
| 1 week | 522.06 |  | 569.44 |
| 1 month | 460.89 | | 569.44 |
| Current year | 416.21 | | 598.79 |
| 1 year | 286.44 | | 615 |
| 3 years | 119.76 | | 615 |
| 5 years | 52.33 | | 615 |
| 10 years | 6.6 | | 615 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 07/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 10/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 20/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 30/06/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 10/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 26/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-16 | Free | Director | 1,220 | 0.0053% | ||
| 06-16 | Free | Director | 1,220 | 0.0053% | ||
| 06-16 | Baker Bros. Advisors LP
| Free | Company | 4,880 | 0.0212% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.95% | +6.04% | +81.47% | +155.56% | 12.91B | |
| -0.33% | -4.41% | +63.62% | +125.88% | 56.98B | |
| +4.91% | -0.19% | +73.70% | +92.14% | 53.58B | |
| +1.48% | +5.97% | +22.59% | +495.47% | 25.63B | |
| -0.59% | -4.68% | -16.82% | -12.99% | 23.51B | |
| +2.43% | +1.06% | +47.70% | -0.11% | 19.43B | |
| -1.15% | +2.17% | +36.89% | -25.28% | 18.12B | |
| -6.84% | +2.18% | +203.03% | +348.11% | 16.46B | |
| +8.74% | +3.51% | +53.81% | - | 14.13B | |
| +1.76% | +2.24% | +29.57% | +195.70% | 14.35B | |
| Average | +0.94% | +1.38% | +59.56% | +152.72% | 25.51B | |
| Weighted average by Cap. | +1.25% | +0.01% | +58.53% | +143.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.5B 1.31B 1.21B 1.12B 2.12B 143B 2.15B 14.45B 5.66B 70.1B 5.61B 5.49B 243B | 2.21B 1.93B 1.78B 1.65B 3.13B 211B 3.18B 21.31B 8.35B 103B 8.28B 8.1B 358B |
| Net income | -201M -176M -162M -150M -285M -19.19B -290M -1.94B -761M -9.42B -755M -738M -32.64B | 308M 269M 248M 230M 436M 29.37B 443M 2.97B 1.17B 14.42B 1.16B 1.13B 49.96B |
| Net Debt | -529M -463M -427M -395M -750M -50.51B -762M -5.11B -2B -24.81B -1.99B -1.94B -85.92B | -1.09B -958M -883M -817M -1.55B -104B -1.58B -10.58B -4.15B -51.31B -4.11B -4.02B -178B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | US$560.01 | -0.95% | 379,035 |
| 08/07/26 | US$565.40 | +3.67% | 468,252 |
| 07/07/26 | US$545.36 | +3.00% | 318,420 |
| 06/07/26 | US$529.48 | +0.26% | 230,982 |
| 02/07/26 | US$528.10 | +2.67% | 221,894 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
